MORPHOSYS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.25 EUR | -0.66% |
|
-.--% | +97.79% |
| Aug. 29 | MorphoSys AG Announces Changes in the Composition of the Supervisory Board | CI |
| Aug. 29 | MorphoSys AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 47.07B | ||||||
| 43.64B | ||||||
| 34.71B | - | |||||
| 30.52B | ||||||
| 26.59B | - |
